EVENTS:   Best Equity Short Ideas Conference Call 12 - Zach Shannon/Corto Capital Advisors & Craig Huber/Huber Research Partners & Thomas Beevers /Forensic Alpha & Ed Steele/Iron Blue Financials & Bill Campbell/Paragon Intel - 12 Nov 25   Will AI Deflate the World? Macro Lessons from Three Industrial Revolutions and China - Manoj Pradhan/Talking Heads Macro - 13 Nov 25     ROADSHOWS: Forest Products Sector Equity and Commodity Research With Expertise in Distressed Debt - Kevin Mason /ERA Research   •   London   12 - 14 Nov 25       Buyside to Buyside Forum and Expert Calls across TMT, Consumer, Healthcare and Fintech - Andrew Peters /Revelare Partners   •   London   17 - 19 Nov 25       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   17 - 19 Nov 25      

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

JELD-WEN (JELD)

Industrials

Thompson Research Group

TRG has long stated that JELD does not have a sales problem but a cost problem. Years of mismanagement has created a huge internal investment and operational improvement opportunity, this sets up a compelling opportunity for investors. JELD sells at ~6x FY24 EBITDA guidance, which TRG believes is a low multiple on the low point of EBITDA. At this moment, Europe EBITDA virtually offsets corporate expenses. Valuing JELD on its North America segment alone on future EBITDA of $441-466m (using a conservative assumption that in 2-3 years the housing market has improved and sales rise 10-13% at a margin of 13.5-13.9%) could yield substantial upside in the stock price.

Edition: 191

- 26 July, 2024